Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,894 | 9,184 | 3,204 | 294 | 676 |
| Receivables | N/A | 818 | N/A | N/A | N/A |
| TOTAL | $7,942 | $10,060 | $3,424 | $893 | $736 |
| Non-Current Assets | |||||
| PPE Net | 1 | 2 | 3 | 4 | N/A |
| Investments And Advances | 57 | 2 | 2 | 2 | 0 |
| Intangibles | 9,347 | 1,587 | 1,587 | 1,587 | 5 |
| Other Non-Current Assets | 19,400 | 19,400 | 19,400 | 19,465 | 0 |
| TOTAL | $28,805 | $20,991 | $20,992 | $21,058 | $5 |
| Total Assets | $36,746 | $31,051 | $24,417 | $21,950 | $742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,714 | 1,573 | 602 | 909 | 559 |
| Accrued Expenses | 1,721 | 1,438 | 1,666 | 1,892 | 8 |
| Other current liabilities | N/A | N/A | 28 | 1,710 | 809 |
| TOTAL | $4,608 | $3,185 | $2,469 | $5,184 | $1,377 |
| Non-Current Liabilities | |||||
| TOTAL | $4,986 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,594 | $3,185 | $2,469 | $5,184 | $1,377 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,157 | 712 | 337 | 198 | 93 |
| Common Shares | 29 | 16 | 8 | 5 | 34 |
| Retained earnings | -53,046 | -40,258 | -27,721 | -17,336 | -9,041 |
| TOTAL | $27,153 | $27,866 | $21,947 | $16,766 | $-635 |
| Total Liabilities And Equity | $36,746 | $31,051 | $24,417 | $21,950 | $742 |